Suchergebnisse - "Memarnejadian, Arash"

PubPharm (111)

1

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran

enthalten in: Intervirology | 2019

von Memarnejadian, A. | Nikpoor, A. | Davoodian, N. | +3

2

The Impact of CRISPR-Cas System on Antiviral Therapy

enthalten in: Advanced pharmaceutical bulletin | 2018

von Bayat, H. | Naderi, F. | Khan, A. | +2

3

Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model

enthalten in: Cancer immunology, immunotherapy : CII | 2018

von Namdar, A. | Mirzaei, R. | Memarnejadian, A. | +10

4

Prevalence of HIV-1 pre-treatment drug resistance in a southern province of Iran, 2016-2017

enthalten in: Archives of virology | 2018

von Memarnejadian, A. | Gouklani, H. | Mohammadi, S. | +2

5

Correction to : Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015

enthalten in: Archives of virology | 2018

von Ghafari, S. | Memarnejadian, A. | Samarbaf-Zadeh, A. | +8

ErratumFor: Arch Virol. 2017 Sep;162(9):2737-2745. - PMID 28589513

6

Correction to: Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015

enthalten in: Archives of virology | 2017

von Ghafari, S. | Memarnejadian, A. | Samarbaf-zadeh, A. | +8

7

Correction to: Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015

enthalten in: Archives of virology | 2017

von Ghafari, S. | Memarnejadian, A. | Samarbaf-zadeh, A. | +8

8

Correction to: Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015

enthalten in: Archives of virology | 2017

von Ghafari, S. | Memarnejadian, A. | Samarbaf-zadeh, A. | +8

9

Prophylactic DNA vaccine targeting $ Foxp3^{+} $ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model

enthalten in: Cancer immunology immunotherapy | 2017

von Namdar, A. | Mirzaei, R. | Memarnejadian, A. | +10

10

Prophylactic DNA vaccine targeting $ Foxp3^{+} $ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model

enthalten in: Cancer immunology immunotherapy | 2017

von Namdar, A. | Mirzaei, R. | Memarnejadian, A. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]